Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Net Income 2008–2025
Biomarin Pharmaceutical Inc. annual/quarterly net income history and growth rate from 2008 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Biomarin Pharmaceutical Inc. net income for the quarter ending March 31, 2026 was 105.5 M, a 43.17% decrease year-over-year.
- Biomarin Pharmaceutical Inc. net income for the twelve months ending March 31, 2026 was 501.0 M, a 46.37% increase year-over-year.
- Biomarin Pharmaceutical Inc. annual net income for 2025 was 348.9 M, a 18.26% decrease from 2024.
- Biomarin Pharmaceutical Inc. annual net income for 2024 was 426.9 M, a 154.62% increase from 2023.
- Biomarin Pharmaceutical Inc. annual net income for 2023 was 167.6 M, a 18.43% increase from 2022.
- Biomarin Pharmaceutical Inc. annual net income for 2022 was 141.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biomarin Pharmaceutical Inc. Net Income — FAQ
Biomarin Pharmaceutical Inc. (BMRN) net income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Biomarin Pharmaceutical Inc.'s net income?
Biomarin Pharmaceutical Inc. (BMRN) reported net income of $349M for fiscal 2025.
Where can I see BMRN's net income history?
The chart and table above show Biomarin Pharmaceutical Inc.'s net income by year and by quarter, including the growth rate.